Literature DB >> 241356

Pharmacological studies of 1-(o-chlorophenyl)-2-tert.-butylaminoethanol (C-78), a new bonchodilator.

S Kubo, Y Kasé, T Miyata, G Kito, I Uesaka.   

Abstract

The bronchodilating effects and other related pharmacological properties of 1-(o-chlorophenyl)-2-tert.-butylaminoethanol-hydrochloride (C-78) were studied in comparison with those of isoproterenol, salbutamol and clorprenaline. C-78 was found to produce a bronchodilating effect 2--10 times stronger and considerably weaker than clorprenaline and isoproterenol, respectively. However, the bronchodilating effect of C-78 was sustained more than 10 times as long as those of isoproterenol and sulbutamol and, especially on oral administration, it was much more potent. The bronchodilating effect of C-78 seems to be due to excitation of the adrenergic beta-receptor, and was antagonized by propranolol. The positive chronotropic and inotropic effects of C-78 on an isolated atrial preparation were less than 1/1000 as potent as those of isoproterenol. C-78 also decreased the tone of smooth muscle, such as the uterus, but its affinity for the bronchial muscle is much higher than for the uterus. C-78 showed strong anti-anaphylactic action and strongly promoted the tracheal ciliary movement. Anitussive effect was also demonstrated, though this was inferior to that of codeine, however, there was no influence on bronchosecretion.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 241356

Source DB:  PubMed          Journal:  Arzneimittelforschung        ISSN: 0004-4172


  6 in total

1.  Electrophysiological effects mediated by the stimulation of cardiac beta 2-adrenoceptors with tulobuterol.

Authors:  A Mugelli; S Amerini; P De Bonfioli Cavalcabo; E Cerbai; S Visentin
Journal:  Cardiovasc Drugs Ther       Date:  1987       Impact factor: 3.727

2.  Bronchodilator activity of a new inhaled beta 2-adrenoceptor agonist, tulobuterol and its protective effect in exercise-induced asthma.

Authors:  K R Patel
Journal:  Br J Clin Pharmacol       Date:  1986-02       Impact factor: 4.335

3.  Comparison of bronchodilator effect of tulobuterol and salbutamol aerosols in patients with asthma.

Authors:  K R Patel
Journal:  Br J Clin Pharmacol       Date:  1985-12       Impact factor: 4.335

4.  The pharmacokinetics of the beta 2-adrenoceptor agonist, tulobuterol, given transdermally and by inhalation.

Authors:  T Uematsu; M Nakano; K Kosuge; M Kanamaru; M Nakashima
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

5.  Protective effect of tulobuterol on methacholine-induced bronchospasm in asthmatic children.

Authors:  A Riba; R Dal-Re; F Morell
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

6.  Prediction of the therapeutic dose for beta-stimulants based on preclinical data: application of oral dosage forms and aerosols to asthmatic patients.

Authors:  K Ito; N Yajima; H Ohtani; Y Yamada; K Nakamura; Y Sawada; T Iga
Journal:  J Pharmacokinet Biopharm       Date:  1993-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.